+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Exoskeleton Market Size, Share & Trends Analysis Report by Technology Type (Mobile, Stationary), by Technology Drive Type, by End User, by Region, and Segment Forecasts, 2020 - 2027

  • ID: 5010935
  • Report
  • March 2020
  • Region: Global
  • 120 pages
  • Grand View Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Cyberdyne, Inc.
  • Ekso Bionics
  • Hocoma
  • RB3D
  • ReWalk Robotics Ltd
  • Rex Bionics Plc.
  • MORE
The global exoskeleton market size is anticipated to reach USD 4.2 billion by 2027, expanding at a CAGR of 26.3% over the forecast period. Growing adoption of exoskeletons in healthcare and non-healthcare settings, reimbursement coverage offered on these systems, and increasing prevalence of spinal cord injuries (SCIs) are the key factors driving the market. Moreover, development in robotics and growing demand for customized exoskeleton that addresses the specific needs of the patients is anticipated to fuel the growth over the forecast period.

Based on technology type, in 2019, mobile exoskeleton dominated the global market, accounting for a revenue share of 61.8%. Introduction of innovative mobile exoskeleton by manufacturers for the aging and disabled population is a key factor driving the market. However, mobile systems are complicated and expensive to design, which increases their cost. This is compelling the patients to switch to the stationary systems, thus making stationary systems the fastest growing segment in the market.

On the basis of technology drive type, in 2019, electric actuators dominated the global exoskeleton market with a share of 32.1% in terms of revenue, as they are cost-effective in comparison with the other drive types. Moreover, presence of a wide variety of commercialized electric actuators is fueling the growth of this electric actuators segment. Usage of fuel cell-powered exoskeleton is increasing in military applications as they provide longer operation hours. This is anticipated to drive the fuel cell segment over the forecast period.

North America dominated the global market in 2019, generating a revenue of USD 297.8 million. Increasing investments in robotics, growing geriatric population, favorable reimbursement policies, and availability of funding for various projects are anticipated to drive the regional market over the forecast period. Asia Pacific is expected to exhibit the fastest CAGR owing to growing geriatric population, improvement in the healthcare infrastructure, and increasing investments in robotics in countries, such as Japan, China, and India.

Further key findings from the report suggest:
  • The global exoskeleton market size is anticipated to reach USD 4.2 billion by 2027 owing to rising applications of these products in healthcare and non-healthcare settings
  • Based on technology type, mobile exoskeleton accounted for a major share of 61.8% in 2019 owing to introduction of innovative mobile systems for various industrial applications
  • On the basis of technology drive type, electric actuators dominated the global market with a revenue share of 32.1% as they are cost-effective than other drive types
  • North America dominated the market with a value of USD 297.8 million in 2019 owing to availability of favorable reimbursement policies and increasing investments in robotics
  • Some of the key players operating in this market are Ekso Bionics, Cyberdyne, ReWalk Laboratories, REX Bionics, and Suit X.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Cyberdyne, Inc.
  • Ekso Bionics
  • Hocoma
  • RB3D
  • ReWalk Robotics Ltd
  • Rex Bionics Plc.
  • MORE
Chapter 1 Research Methodology

1.1 Information Procurement

Chapter 2 Executive Summary

Chapter 3 Exoskeleton Industry Outlook
3.1 Market Segmentation
3.2 Market Size and Growth Prospects, 2016 - 2027
3.3 Exoskeleton Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Growing technological advancements
3.3.1.2 Increasing prevalence of strokes and spinal cord injuries leading to disabilities
3.3.1.3 Increasing geriatric population
3.3.2 Market restraint analysis
3.3.2.1 High costs of the exoskeleton devices restraints the adoption of home use
3.3.2.2 Lack of reimbursements
3.4 Key Opportunities Prioritized
3.5 Industry Analysis - Porter’s
3.6 Exoskeleton PESTEL Analysis
3.7 Key Product/ Brand Outlook
3.8 Research Funding Outlook
3.9 Regulatory and Safety Outlook
3.10 Exoskeleton Technology Comparative Analysis
3.10.1 Mobile vs. stationary systems
3.10.2 Active vs. passive systems

Chapter 4 Exoskeleton Market: Technology (Type) Estimates & Trend Analysis
4.1 Global Exoskeleton Market: Technology (by type) Movement Analysis & Market Share, 2019 & 2027
4.2 Mobile
4.2.1 Mobile exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
4.2.2 Active
4.2.2.1 Active mobile exoskeleton market estimates and forecasts, 2016- 2027 (USD Million)
4.2.3 Passive
4.2.3.1 Passive mobile market estimates and forecasts, 2016 - 2027 (USD Million)
4.3 Stationary
4.3.1 Stationary exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
4.3.2 Active
4.3.2.1 Active stationary exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
4.3.3 Passive
4.3.3.1 Passive stationary market estimates and forecasts, 2016 - 2027 (USD Million)

Chapter 5 Exoskeleton Market: Technology (by Drive Type) Estimates & Trend Analysis
5.1 Global Exoskeleton Market: Technology (by Drive Type) Movement Analysis & Market Share, 2019 & 2027
5.2 Pneumatic Actuator
5.2.1 Pneumatic actuator exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
5.3 Hydraulic Actuator
5.3.1 Hydraulic actuators exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
5.4 Electric Servo
5.4.1 Electric servo exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
5.5 Electric Actuator
5.5.1 Electric actuator exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
5.6 Fully Mechanical
5.6.1 Fully mechanical exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
5.7 Shape Memory Alloy Actuator
5.7.1 Shape memory alloy actuator exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
5.8 Fuel Cell
5.8.1 Fuel cell exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)

Chapter 6 Exoskeleton Market: End User Estimates & Trend Analysis
6.1 Global Exoskeleton Market: End User Movement Analysis
6.2 End User Movement Analysis& Market Share, 2019 & 2027
6.3 Healthcare
6.3.1 Healthcare exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
6.3.2 Healthcare rehabilitation centers
6.3.2.1 Healthcare rehabilitation centers exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
6.3.3 Healthcare elderly care
6.3.3.1 Healthcare elderly care exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
6.3.4 Healthcare assisted living facilities
6.3.4.1 Healthcare assisted living facilities exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
6.4 Military
6.4.1 Military exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
6.5 Industrial
6.5.1 Industrial exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
6.5.2 Industrial production
6.5.3 Industrial production exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
6.5.4 Industrial construction
6.5.5 Industrial construction exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
6.5.6 Industrial logistics
6.5.7 Industrial logistics exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)

Chapter 7 Exoskeleton Market: Regional Estimates & Trend Analysis, by Product & Application
7.1 Regional Movement Analysis & Market Share, 2019 & 2027
7.2 North America
7.2.1 North America exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. Exoskeletons market estimates and forecasts, 2016 - 2027 (USD Million)
7.2.3 Canada
7.2.3.1 Canada exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
7.3 Europe
7.3.1 Europe exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
7.3.2 Germany
7.3.2.1 Germany exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
7.3.3 U.K.
7.3.3.1 U.K. exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
7.3.4 France
7.3.4.1 France exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
7.3.5 Italy
7.3.5.1 Italy exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
7.3.6 Spain
7.3.6.1 Spain exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
7.3.7 Switzerland
7.3.7.1 Switzerland exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
7.4.2 Japan
7.4.2.1 Japan exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
7.4.3 China
7.4.3.1 China exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
7.5 Latin America
7.5.1 Latin America exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
7.6 MEA
7.6.1 MEA exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa exoskeleton market estimates and forecasts, 2016 - 2027 (USD Million)

Chapter 8 Competitive Landscape
8.1 Company Categorization (Key Innovators, Market Leaders, Emerging Players)
8.2 Company Market Position Analysis
8.3 Company Market Share Analysis, 2019
8.4 Market Differentiators
8.5 Key Customers
8.6 List of Key Emerging Companies
8.7 Company Profiles
8.7.1 Ekso Bionics
8.7.1.1 Company Overview
8.7.1.2 Financial Performance
8.7.1.3 Product Benchmarking
8.7.1.4 Strategic Initiatives
8.7.2 ActiveLink (Panasonic Corporation)
8.7.2.1 Company Overview
8.7.2.2 Financial Performance
8.7.2.3 Product Benchmarking
8.7.2.4 Strategic Initiatives
8.7.3 Cyberdyne, Inc.
8.7.3.1 Company Overview
8.7.3.2 Financial Performance
8.7.3.3 Product Benchmarking
8.7.3.4 Strategic Initiatives
8.7.4 ReWalk Robotics Ltd
8.7.4.1 Company Overview
8.7.4.2 Financial Performance
8.7.4.3 Product Benchmarking
8.7.4.4 Strategic Initiatives
8.7.5 Rex Bionics Plc.
8.7.5.1 Company Overview
8.7.5.2 Financial Performance
8.7.5.3 Product Benchmarking
8.7.5.4 Strategic Initiatives
8.7.6 Lockheed Martin Corporation
8.7.6.1 Company Overview
8.7.6.2 Financial Performance
8.7.6.3 Product Benchmarking
8.7.6.4 Strategic Initiatives
8.7.7 Suit X (U.S. Bionics, Inc.)
8.7.7.1 Company Overview
8.7.7.2 Financial Performance
8.7.7.3 Product Benchmarking
8.7.7.4 Strategic Initiatives
8.7.8 RB3D
8.7.8.1 Company Overview
8.7.8.2 Financial Performance
8.7.8.3 Product Benchmarking
8.7.8.4 Strategic Initiatives
8.7.9 Hocoma
8.7.9.1 Company Overview
8.7.9.2 Financial Performance
8.7.9.3 Product Benchmarking
8.7.9.4 Strategic Initiatives

Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Ekso Bionics
  • ActiveLink (Panasonic Corporation)
  • Cyberdyne, Inc.
  • ReWalk Robotics Ltd
  • Rex Bionics Plc.
  • Lockheed Martin Corporation
  • Suit X (U.S. Bionics, Inc.)
  • RB3D
  • Hocoma
Note: Product cover images may vary from those shown
Adroll
adroll